TABLE 1.
Clinical characteristics of individuals participating in this study.
|
Discovery |
In silico replication |
De novo typing† |
||||
| case | control | case | control | case | control | |
| N | 150 | 100 | 96 | 96 | 139 | 96 |
| Age at diagnosis (year) | 15.8 ± 7.3 | 16.0 ± 7.1 | 16.2 | 16.3 | 16.86 ± 7.9 | 12.5 ± 7.3 |
| Duration of diabetes (year) | 26.6 ± 8.8 | 27.1 ± 8.6 | 27.5 | 27.8 | 30.1 ± 8.8 | 23.2 ± 7.4 |
| HBA1c (%) | 8.9 ± 2.0 | 8.8 ± 1.6 | Not reported | Not reported | 10.1 ± 2.0 | 9.5 ± 1.6 |
| HBA1c (mmol/mol from www.ngsp.org/convert1.asp) | 74 | 73 | 87 | 80 | ||
| Male (%) | 49 | 49 | 50.0 | 49.0 | 54.0 | 41.7 |
†De novo genotyping group includes several individuals that were part of the in silico replication for cg02399570 and cg04861640 markers, which were not analyzed on the HumanMethylation27 BeadChip.